BeyondSpring Inc/ KYG108301006 /
| 26/09/2024 22:00:00 | Chg. 0.0000 | Volume | Bid22:00:14 | Ask22:00:14 | High | Low |
|---|---|---|---|---|---|---|
| 2.0500USD | 0.00% | 26,632 Turnover: 51,689.3294 |
2.0200Bid Size: 3,000 | 2.1200Ask Size: 100 | 2.1300 | 2.0330 |
GlobeNewswire
06/08
SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discov...
GlobeNewswire
16/05
BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire
03/05
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and U...
GlobeNewswire
29/04
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
GlobeNewswire
25/03
BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in...
GlobeNewswire
26/02
BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements
GlobeNewswire
10/01
BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K
GlobeNewswire
18/12/2023
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
GlobeNewswire
07/11/2023
BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of ...
GlobeNewswire
31/10/2023
BeyondSpring and Professor K. Eisenmann of the University of Toledo College of Medicine Present Post...
GlobeNewswire
26/10/2023
SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degra...
GlobeNewswire
23/10/2023
SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors
GlobeNewswire
04/10/2023
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
GlobeNewswire
27/09/2023
BeyondSpring and Leading Cancer Center to Present Poster at SITC’s 38th Annual Meeting
GlobeNewswire
07/09/2023
BeyondSpring to Participate in the R.W. Baird’s 2023 Global Healthcare Conference
GlobeNewswire
04/01/2022
Vaxxinity Appoints Jason Pesile as SVP, Finance & Accounting, and George Hornig to Board of Director...
GlobeNewswire
30/12/2021
BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
GlobeNewswire
15/12/2021
BeyondSpring Pharmaceuticals Announces New Clinical Data Confirming Plinabulin’s Fast Onset Mechanis...
GlobeNewswire
10/12/2021
BeyondSpring Pharmaceuticals Announces Analysis of New Data on the Plinabulin/Pegfilgrastim Combinat...
GlobeNewswire
07/12/2021
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BeyondSpring Inc...
